Cavitation Technologies (CVAT) Cash & Equivalents (2010 - 2026)

Cavitation Technologies has disclosed Cash & Equivalents across 17 years of filings, most recently posting $45000.0 for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $45000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $45000.0 (changed N/A YoY), and the FY2025 annual result was $249000.0, changed N/A from the prior year.
• Cash & Equivalents came in at $45000.0 for Q1 2026 at Cavitation Technologies, up from $31000.0 in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $779000.0 in Q1 2022 to a low of $2000.0 in Q3 2024.
• The 5-year median for Cash & Equivalents is $161500.0 (2023), against an average of $207166.7.
• Across the five-year window, Cash & Equivalents tumbled 98.57% in 2024 and surged 1400.0% in 2025, its largest moves.
• Cavitation Technologies' Cash & Equivalents stood at $343000.0 in 2022, then slumped by 97.96% to $7000.0 in 2023, then sank by 71.43% to $2000.0 in 2024, then jumped by 1450.0% to $31000.0 in 2025, then soared by 45.16% to $45000.0 in 2026.
• The last three Cash & Equivalents figures came in at $45000.0 (Q1 2026), $31000.0 (Q4 2025), and $30000.0 (Q3 2025), per Business Quant data.